Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients

The FDA approved Novartis’ radiopharma drug Pluvicto for use alongside hormone therapy, making the drug available to many more patients. The approval nearly doubles the eligible patient population for Pluvicto, according to a Novartis

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

James Ellis Ford – “The Ever After”

Most of us know James Ellis Ford as the producer of some of the most important UK albums of the past 20 years or so. But when his own life circumstances become extreme enough, like his current battle…

‘Morning Joe’ Fact-Checks RFK Jr.’s Latest ‘Outrageous’ Covid Claims: ‘It’s a Lie’

"Many of his claims flat-out contradict established scientific evidence," MS NOW co-host Jonathan Lemire says after the HHS secretary's interview with Dana Bash on CNN The post ‘Morning Joe’…

  • Jonathan Lemire debunked RFK Jr.'s Covid claims as "false" and "outrageous" on "Morning Joe"
  • ICUs were not empty as Kennedy claimed; FEMA sent refrigerated trucks to NYC in March 2020

More from Monday 3 August →